Clinical Trial Update: Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of Ifetroban for portal hypertension in cirrhotic patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• Ifetroban (Ifetroban)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Portal Hypertension, Liver Cirrhosis | Phase 2 | Status: COMPLETED | Results posted: 2022-01-19